Back to News
Market Impact: 0.35

Jacobs Is Trading at a Discount: Should You Buy or Hold the Stock?

ACMEMEJMRKNDAQNVDASTRL
Company FundamentalsAnalyst EstimatesCorporate EarningsCorporate Guidance & OutlookInfrastructure & DefenseTechnology & Innovation
Jacobs Is Trading at a Discount: Should You Buy or Hold the Stock?

Jacobs Solutions Inc. is currently trading at a discount to its peers with a forward 12-month P/E ratio of 18.97X, below the industry average of 24.73X, driven by rising costs and unfavorable currency movements despite a 5% gain in the past month; however, a robust backlog of $22.16 billion, up 20% year-over-year, and steady demand in key markets like infrastructure and data centers support revenue growth prospects, with the company forecasting a 5% to 7% year-over-year increase in net revenues for the fiscal third quarter.

Analysis

Jacobs Solutions Inc. (J) is currently trading at a noticeable discount, with a forward 12-month P/E ratio of 18.97X, significantly below its Technology Services industry peers (24.73X) and comparable companies such as EMCOR Group (19.75X), AECOM (20X), and Sterling Infrastructure (21.87X). This valuation gap exists despite a 5% gain in its stock price over the past month, which underperformed the industry's 15.7% increase, primarily attributed to rising direct costs and adverse foreign currency movements; for instance, unfavorable FX impacted revenues by $2.3 million in the first six months of fiscal 2025. However, Jacobs' growth prospects are substantially supported by a robust backlog, which reached $22.16 billion at the end of Q2 fiscal 2025, a 20% year-over-year increase, with the Infrastructure & Advanced Facilities segment backlog at $21.77 billion. The company anticipates 5% to 7% year-over-year growth in net revenues for the fiscal third quarter, largely driven by this existing backlog. Strong demand persists in key markets including Water and Environmental services, Life Sciences (which saw double-digit revenue growth in Q2 fiscal 2025, supported by projects like Merck's $1 billion facility), and an expanding presence in Data Center Infrastructure, highlighted by its selection for PsiQuantum's quantum computing facility and a collaboration with NVIDIA on AI factory digital twins. Fiscal 2025 earnings are estimated to grow 13.8% year-over-year, although this estimate has seen a downward revision. While these growth drivers are compelling, pressures from increased labor expenses, operational investments, and a stronger U.S. dollar impacting overseas revenues remain pertinent concerns for near-term margin performance.